Glaxo Wellcome Biofarma (Cell Manufacturing facility in Porrino) is Buildings and Property in Spain that focus on cell culture manufacturing facility business. Founded in 1976. They cover business area such as Porrino, Spain, area, several large-scale cell culture bioreactor, facility, administration office.
1976
( 48 years old in 2024 )
Cell Culture Manufacturing Facility
-
Porrino
Spain
Private
PorrinoSpainareaseveral large-scale cell culture bioreactorfacilityadministration office
* We use standard office opening hours in near Glaxo Wellcome Biofarma (Cell Manufacturing facility in Porrino)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Glaxo Wellcome Biofarma (Cell Manufacturing Facility In Porrino) is Buildings and Property business from Spain that founded in 1976 (48 years old in 2024), Glaxo Wellcome Biofarma (Cell Manufacturing facility in Porrino) business is focusing on Cell Culture Manufacturing Facility.
Glaxo Wellcome Biofarma (Cell Manufacturing facility in Porrino) headquarter office and corporate office address is located in Porrino Spain.
Glaxo Wellcome Biofarma (Cell Manufacturing facility in Porrino) was founded in Spain.
In 2024, Glaxo Wellcome Biofarma (Cell Manufacturing facility in Porrino) is currently focus on cell culture manufacturing facility sector.
Above is snippet of Google Trends for "cell culture manufacturing facility" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Glaxo Wellcome Biofarma (Cell Manufacturing facility in Porrino), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
